Locomotor stimulant effects of nornicotine

Role of dopamine

Thomas Green, R. W. Brown, S. B. Phillips, L. P. Dwoskin, M. T. Bardo

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Nornicotine (NORNIC) is a tobacco alkaloid and behaviorally active nicotine metabolite in vivo. Previous behavioral research has shown that NORNIC has locomotor stimulant and reinforcing effects in rats similar to that of nicotine. Results from the current study showed that a bilateral lesion of the nucleus accumbens decreased the locomotor stimulant effect of NORNIC across repeated injections. Pretreatment with the dopamine (DA) D1 receptor antagonist SCH23390 did not block the locomotor stimulant effect of NORNIC or the initiation of sensitization following repeated NORNIC administration. The D2 receptor antagonist eticlopride, however, blocked both the stimulant effect and the initiation of sensitization following repeated NORNIC. Additionally, NORNIC was found to increase synthesis and metabolism of DA, with a greater effect in the mesolimbic pathway compared to the nigrostriatal pathway. Taken together, these results suggest that expression of NORNIC-induced locomotor activity is dependent upon ascending dopaminergic mesolimbic projections, providing additional evidence that NORNIC plays a contributory role in tobacco dependence.

Original languageEnglish (US)
Pages (from-to)87-94
Number of pages8
JournalPharmacology Biochemistry and Behavior
Volume74
Issue number1
DOIs
StatePublished - Dec 2002
Externally publishedYes

Fingerprint

nornicotine
Dopamine
eticlopride
Tobacco
Nicotine
Behavioral research
Behavioral Research
Dopamine D1 Receptors
Tobacco Use Disorder
Dopamine Antagonists
Nucleus Accumbens

Keywords

  • Activity
  • Behavior
  • DOPAC
  • Locomotion
  • Metabolism
  • Nicotine metabolite
  • Sensitization
  • Synthesis
  • Tobacco alkaloid
  • Tolerance

ASJC Scopus subject areas

  • Biochemistry
  • Behavioral Neuroscience
  • Pharmacology

Cite this

Locomotor stimulant effects of nornicotine : Role of dopamine. / Green, Thomas; Brown, R. W.; Phillips, S. B.; Dwoskin, L. P.; Bardo, M. T.

In: Pharmacology Biochemistry and Behavior, Vol. 74, No. 1, 12.2002, p. 87-94.

Research output: Contribution to journalArticle

Green, Thomas ; Brown, R. W. ; Phillips, S. B. ; Dwoskin, L. P. ; Bardo, M. T. / Locomotor stimulant effects of nornicotine : Role of dopamine. In: Pharmacology Biochemistry and Behavior. 2002 ; Vol. 74, No. 1. pp. 87-94.
@article{e8b15f815a6241048611a8021c96a14b,
title = "Locomotor stimulant effects of nornicotine: Role of dopamine",
abstract = "Nornicotine (NORNIC) is a tobacco alkaloid and behaviorally active nicotine metabolite in vivo. Previous behavioral research has shown that NORNIC has locomotor stimulant and reinforcing effects in rats similar to that of nicotine. Results from the current study showed that a bilateral lesion of the nucleus accumbens decreased the locomotor stimulant effect of NORNIC across repeated injections. Pretreatment with the dopamine (DA) D1 receptor antagonist SCH23390 did not block the locomotor stimulant effect of NORNIC or the initiation of sensitization following repeated NORNIC administration. The D2 receptor antagonist eticlopride, however, blocked both the stimulant effect and the initiation of sensitization following repeated NORNIC. Additionally, NORNIC was found to increase synthesis and metabolism of DA, with a greater effect in the mesolimbic pathway compared to the nigrostriatal pathway. Taken together, these results suggest that expression of NORNIC-induced locomotor activity is dependent upon ascending dopaminergic mesolimbic projections, providing additional evidence that NORNIC plays a contributory role in tobacco dependence.",
keywords = "Activity, Behavior, DOPAC, Locomotion, Metabolism, Nicotine metabolite, Sensitization, Synthesis, Tobacco alkaloid, Tolerance",
author = "Thomas Green and Brown, {R. W.} and Phillips, {S. B.} and Dwoskin, {L. P.} and Bardo, {M. T.}",
year = "2002",
month = "12",
doi = "10.1016/S0091-3057(02)00960-7",
language = "English (US)",
volume = "74",
pages = "87--94",
journal = "Pharmacology Biochemistry and Behavior",
issn = "0091-3057",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Locomotor stimulant effects of nornicotine

T2 - Role of dopamine

AU - Green, Thomas

AU - Brown, R. W.

AU - Phillips, S. B.

AU - Dwoskin, L. P.

AU - Bardo, M. T.

PY - 2002/12

Y1 - 2002/12

N2 - Nornicotine (NORNIC) is a tobacco alkaloid and behaviorally active nicotine metabolite in vivo. Previous behavioral research has shown that NORNIC has locomotor stimulant and reinforcing effects in rats similar to that of nicotine. Results from the current study showed that a bilateral lesion of the nucleus accumbens decreased the locomotor stimulant effect of NORNIC across repeated injections. Pretreatment with the dopamine (DA) D1 receptor antagonist SCH23390 did not block the locomotor stimulant effect of NORNIC or the initiation of sensitization following repeated NORNIC administration. The D2 receptor antagonist eticlopride, however, blocked both the stimulant effect and the initiation of sensitization following repeated NORNIC. Additionally, NORNIC was found to increase synthesis and metabolism of DA, with a greater effect in the mesolimbic pathway compared to the nigrostriatal pathway. Taken together, these results suggest that expression of NORNIC-induced locomotor activity is dependent upon ascending dopaminergic mesolimbic projections, providing additional evidence that NORNIC plays a contributory role in tobacco dependence.

AB - Nornicotine (NORNIC) is a tobacco alkaloid and behaviorally active nicotine metabolite in vivo. Previous behavioral research has shown that NORNIC has locomotor stimulant and reinforcing effects in rats similar to that of nicotine. Results from the current study showed that a bilateral lesion of the nucleus accumbens decreased the locomotor stimulant effect of NORNIC across repeated injections. Pretreatment with the dopamine (DA) D1 receptor antagonist SCH23390 did not block the locomotor stimulant effect of NORNIC or the initiation of sensitization following repeated NORNIC administration. The D2 receptor antagonist eticlopride, however, blocked both the stimulant effect and the initiation of sensitization following repeated NORNIC. Additionally, NORNIC was found to increase synthesis and metabolism of DA, with a greater effect in the mesolimbic pathway compared to the nigrostriatal pathway. Taken together, these results suggest that expression of NORNIC-induced locomotor activity is dependent upon ascending dopaminergic mesolimbic projections, providing additional evidence that NORNIC plays a contributory role in tobacco dependence.

KW - Activity

KW - Behavior

KW - DOPAC

KW - Locomotion

KW - Metabolism

KW - Nicotine metabolite

KW - Sensitization

KW - Synthesis

KW - Tobacco alkaloid

KW - Tolerance

UR - http://www.scopus.com/inward/record.url?scp=0036887558&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036887558&partnerID=8YFLogxK

U2 - 10.1016/S0091-3057(02)00960-7

DO - 10.1016/S0091-3057(02)00960-7

M3 - Article

VL - 74

SP - 87

EP - 94

JO - Pharmacology Biochemistry and Behavior

JF - Pharmacology Biochemistry and Behavior

SN - 0091-3057

IS - 1

ER -